These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31919051)

  • 1. Role of angiopoietin-like protein 3 in sugar-induced dyslipidemia in rhesus macaques: suppression by fish oil or RNAi.
    Butler AA; Graham JL; Stanhope KL; Wong S; King S; Bremer AA; Krauss RM; Hamilton J; Havel PJ
    J Lipid Res; 2020 Mar; 61(3):376-386. PubMed ID: 31919051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fructose-induced hypertriglyceridemia in rhesus macaques is attenuated with fish oil or ApoC3 RNA interference.
    Butler AA; Price CA; Graham JL; Stanhope KL; King S; Hung YH; Sethupathy P; Wong S; Hamilton J; Krauss RM; Bremer AA; Havel PJ
    J Lipid Res; 2019 Apr; 60(4):805-818. PubMed ID: 30723097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish oil supplementation ameliorates fructose-induced hypertriglyceridemia and insulin resistance in adult male rhesus macaques.
    Bremer AA; Stanhope KL; Graham JL; Cummings BP; Ampah SB; Saville BR; Havel PJ
    J Nutr; 2014 Jan; 144(1):5-11. PubMed ID: 24108131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low plasma adropin concentrations increase risks of weight gain and metabolic dysregulation in response to a high-sugar diet in male nonhuman primates.
    Butler AA; Zhang J; Price CA; Stevens JR; Graham JL; Stanhope KL; King S; Krauss RM; Bremer AA; Havel PJ
    J Biol Chem; 2019 Jun; 294(25):9706-9719. PubMed ID: 30988006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia.
    Chen PY; Gao WY; Liou JW; Lin CY; Wu MJ; Yen JH
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia.
    Ruscica M; Zimetti F; Adorni MP; Sirtori CR; Lupo MG; Ferri N
    Pharmacol Res; 2020 Mar; 153():104653. PubMed ID: 31931117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia.
    Shoji T; Hatsuda S; Tsuchikura S; Kimoto E; Kakiya R; Tahara H; Koyama H; Emoto M; Tabata T; Nishizawa Y
    Atherosclerosis; 2009 Dec; 207(2):579-84. PubMed ID: 19540497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of angiopoietin-like protein 3 (ANGPTL3) levels in polycystic ovary syndrome.
    Vatannejad A; Salimi F; Moradi N; Fouani FZ; Zandieh Z; Ansaripour S; Sadeghi A; Fadaei R
    Life Sci; 2020 Dec; 263():118595. PubMed ID: 33075372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.
    Su X; Peng DQ
    Lipids Health Dis; 2018 Jan; 17(1):12. PubMed ID: 29334984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes.
    Christopoulou E; Elisaf M; Filippatos T
    Dis Markers; 2019; 2019():6578327. PubMed ID: 30944669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides.
    Graham MJ; Lee RG; Brandt TA; Tai LJ; Fu W; Peralta R; Yu R; Hurh E; Paz E; McEvoy BW; Baker BF; Pham NC; Digenio A; Hughes SG; Geary RS; Witztum JL; Crooke RM; Tsimikas S
    N Engl J Med; 2017 Jul; 377(3):222-232. PubMed ID: 28538111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation.
    Athyros VG; Katsiki N; Dimakopoulou A; Patoulias D; Alataki S; Doumas M
    Curr Pharm Des; 2018; 24(31):3638-3646. PubMed ID: 30306859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3).
    Ginsberg HN; Goldberg IJ
    Arterioscler Thromb Vasc Biol; 2023 Mar; 43(3):388-398. PubMed ID: 36579649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells.
    Chen PY; Chao TY; Hsu HJ; Wang CY; Lin CY; Gao WY; Wu MJ; Yen JH
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPK-SIRT1-independent inhibition of ANGPTL3 gene expression is a potential lipid-lowering mechanism of metformin.
    Lin L; Burke J; Venkatesh S; Sadana P
    J Pharm Pharmacol; 2019 Sep; 71(9):1421-1428. PubMed ID: 31273790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANGPTL3 is part of the machinery causing dyslipidemia majorily via LPL inhibition in mastitis mice.
    Xiao HB; Wang JY; Sun ZL
    Exp Mol Pathol; 2017 Dec; 103(3):242-248. PubMed ID: 29104012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between ANGPTL3, 4, and 8 and lipid and glucose metabolism markers in patients with diabetes.
    Harada M; Yamakawa T; Kashiwagi R; Ohira A; Sugiyama M; Sugiura Y; Kondo Y; Terauchi Y
    PLoS One; 2021; 16(7):e0255147. PubMed ID: 34293055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-like proteins inhibitors: New horizons in the treatment of atherogenic dyslipidemia and familial hypercholesterolemia.
    Surma S; Romańczyk M; Filipiak KJ
    Cardiol J; 2023; 30(1):131-142. PubMed ID: 33470417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopoietin-like protein 3, an emerging cardiometabolic therapy target with systemic and cell-autonomous functions.
    Ruhanen H; Haridas PAN; Jauhiainen M; Olkkonen VM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158791. PubMed ID: 32777482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANGPTL3 as therapeutic target.
    Kersten S
    Curr Opin Lipidol; 2021 Dec; 32(6):335-341. PubMed ID: 34581310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.